Young, a specialist in awake tumescent laser liposuction
According to the National Institute of Diabetes and Digestive and Kidney Diseases, GLP-1 receptor agonists now produce 3 to 12% more weight loss than lifestyle intervention alone
Both semaglutide and tirzepatide are given as once-a-week subcutaneous injections , which adds a level of convenience for patients managing ongoing treatment
In the study, participants with a responsive genetic score had an 82% increase in the likelihood of acheiving weight loss with a GLP-1 medication.[ref] Another study showed that GLP1 receptor variants are associated with greater weight loss on GLP-1 RA drugs.[ref] Common genetic variants in the GLP1R (GLP-1 receptor) gene impact weight and type 2 diabetes risk
In Utah, semaglutide injections can be given by professionals with the titles MD, DO, NP, APRN, PA, RN, or LPN
The only difference is FDA approval indication: Mounjaro is approved for type 2 diabetes, while Zepbound is approved for weight loss